Rubedo anti-aging cream cut skin biological age by 2 years in 4 weeks

Rubedo Life Sciences reported early clinical data for its senolytic topical cream: in 11 patients with atopic dermatitis, skin biological age dropped by about two years on average after four weeks, with one participant improving by more than 11 years. The drug targets the GPX4 protein to clear senescent cells.

• 11 atopic dermatitis patients used the cream for four weeks
• Average skin biological age fell by about 2 years
• One participant's skin age improved by more than 11 years
• In a separate 18-person trial, actinic keratosis lesions dropped 46%